Results: 32

Quality of life in women with migraine: a systematic review

Introduction: Several chronic diseases interfere with quality of life (QoL), including migraine, especially in women who are the most affected. However, effective therapeutic interventions are capable of modifying the disease. Objective: Our objective was to review the literature on QoL in women with mig...

Treatment of refrectory migraine in emergency departament

Background: Headaches are among the most common neurological complaints in emergency care, predominantly affecting young women of childbearing age. Migraines, as a subtype, are particularly disabling, significantly reducing quality of life and posing a burden on healthcare systems. When standard preventi...

Toxina botulínica no tratamento da enxaqueca crônica: uma revisão sistemática

Clin. biomed. res; 43 (2), 2023
A enxaqueca crônica é causada por alterações químicas do cérebro, dores unilaterais, pulsáteis de intensidade variável. A administração da toxina botulínica, neurotoxina produzida peloClostridium botulinum, é uma alternativa de tratamento. Existem diferentes preparações da toxina botulínic...

Migraine treatment with biological therapies. The state of the art

Migraine is a highly prevalent and debilitating neurological disorder. Most patients do not receive a correct diagnosis and effective treatments. Apart of the few specialists and tertiary centers worldwide, the treatment of migraine is usually symptomatic and prevention, as well as treatments of the unde...

Corticoesteroides: su utilidad en el abordaje farmacológico de la crisis de migraña

RESUMEN: La migraña es una cefalea primaria frecuente y debilitante. Los pacientes con crisis de migraña agudas y severas usualmente deben consultar por servicios de guardia, y el tratamiento convencional para el ataque de migraña incluye diversos fármacos como antiinflamatorios no esteroideos, tript...

Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?

Arq. neuropsiquiatr; 79 (10), 2021
ABSTRACT Background: Botulinum toxin Type A (BoNTA) is a successful treatment for chronic migraine prophylaxis. Objective: We aimed to evaluate the monthly change of effectiveness of BoNTA treatment. Methods: A total of 80 patients (70 females and 10 males) with chronic migraine were included. In o...

Evaluation of structural changes in orbitofrontal cortex in relation to medication overuse in migraine patients: a diffusion tensor imaging study

Arq. neuropsiquiatr; 79 (6), 2021
Abstract Background: Migraine is a prevalent neurological disease that leads to severe headaches. Moreover, it is the commonest among the primary headaches that cause medication overuse headache (MOH). The orbitofrontal cortex (OFC) is one of the structures most associated with medication overuse. Obje...

Tratamiento preventivo en migraña: anticuerpos monoclonales contra la vía del péptido relacionado con el gen de la calcitonina

Medicina (B.Aires); 81 (3), 2021
Resumen La migraña es un trastorno muy prevalente que afecta a alrededor del 15% de los sujetos adultos. Es clasificada por la Organización Mundial de la Saludentre los primeros puestos como causa de discapacidad. Los tratamientos preventivos habituales hasta ahora derivan de otras indicaciones y por s...

Migrânea e terapia hormonal
Migraine and hormone therapy

Femina; 49 (10), 2021

Comparación de tres estrategias de tratamiento para la cefalea por sobreuso de medicación
Comparison of three treatment strategies for medication overuse headache